
News|Articles|May 23, 2024
Eurofins MDT adds biological evaluations to support biocompatibility strategies
Author(s)Eurofins BioPharma Product Testing
The Toxicology Team in Lancaster now offers expanded services including biological evaluations to help clients with biocompatibility strategies and regulatory compliance. We provide tailored consulting for specific needs like mitigating biological risks due to product changes or failed tests. Each project is evaluated individually, ensuring customized solutions and enhanced client value.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Amgen Acquires UK Biotech Dark Blue Therapeutics
2
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
3
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 2: A Detailed Assessment for Specification Equivalence
4
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
5